This statistic shows the distribution of incrementally modified drugs approved in South Korea from 2009 to 2016, by type. During this time period, osteoporosis drugs accounted for 19.5 percent of the total incrementally modified drugs approved in South Korea.
Distribution of incrementally modified drugs approved in South Korea from 2009 to 2016, by type
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Basic Statistic Share of global fentanyl consumption 2018-2022, by country
- Premium Statistic Anti-diabetics estimated market size in South Korea 2014-2020
- Basic Statistic Registrations to produce medical marijuana for personal-use Canada 2023, by province
- Basic Statistic Global extraction of alkaloids from opium by type 2014-2022
- Premium Statistic Global consumption of major opium alkaloids and derivatives 2014-2022
- Basic Statistic Global consumption of major synthetic opioids by type 2014-2022
- Basic Statistic Manufacture of global opium alkaloids and derivatives by type 2013-2022
- Basic Statistic Consumption of major synthetic opioids by type in the U.S. 2014-2022
- Basic Statistic Manufacture of opium alkaloids and derivatives by type U.S. 2013-2022
- Premium Statistic Manufacture of global synthetic opioids by type 2013-2022
About the region
9
- Premium Statistic Anti-cancer drugs estimated market size in South Korea 2014-2020
- Premium Statistic Food etc. testing and inspection agencies in South Korea 2022, by type
- Premium Statistic Foreign food etc. testing laboratory approvals by South Korea 2008-2021
- Premium Statistic Foreign food etc. testing laboratories approved by South Korea 2021, by nation
- Premium Statistic Cardiovascular disease drugs estimated market size in South Korea 2014-2020
- Premium Statistic Cholesterol drugs estimated market size in South Korea 2014-2020
- Premium Statistic Bank customer satisfaction index in South Korea 2021
- Premium Statistic Decaffeinated green coffee import volume in South Korea 2022, by origin
- Premium Statistic Decaffeinated green coffee import value in South Korea 2022, by origin
Selected statistics
1
Other regions
10
- Basic Statistic Coca leaf imports in the U.S. 2014-2022
- Premium Statistic Europe: value of selected medical markets 2015 and 2022
- Premium Statistic Share of global morphine consumption by region 2018-2022
- Premium Statistic Osteoporosis drug market size in China 2008-2016
- Basic Statistic Drug therapy nonadherence rate in Canada in 2019, by therapy class
- Premium Statistic Most sold medicine in Romania during the COVID-19 pandemic 2020
- Premium Statistic Volume of medicines dispensed in pharmacies reimbursed in France 2014, by class
- Premium Statistic Physicians that received opioid-manufacturer payments in New York 2013-2015
- Premium Statistic Athletes subject to doping controls in Italy H1 2019, by sport
- Premium Statistic Mexico: prevalence of tobacco use among teenagers in 2011-2016, by gender
Related statistics
10
- Premium Statistic Pharmaceuticals market size South Korea 2012-2022
- Premium Statistic E-sports club budget scale South Korea 2015-2022
- Premium Statistic Watching OTT video devices in South Korea 2021
- Premium Statistic Average number of video game consoles per household in South Korea 2013-2023
- Premium Statistic Professional gamer post retirement plan in South Korea 2020
- Premium Statistic Changes in outpatient prescriptions during COVID-19 in Seoul South Korea 2020
- Premium Statistic Changes in outpatient prescriptions in Gwangju and Jeolla South Korea 2020
- Premium Statistic Impact of COVID-19 on OTC pharmacy sales South Korea 2020
- Premium Statistic Impact of COVID-19 on revenue of hospitality and retail sector South Korea 2020
- Premium Statistic Spending on takeaways in South Korea 2014-2019
Further related statistics
10
- Merck & Co total assets 2009-2023
- Sanofi's total assets 2007-2023
- Merck & Co - expenditure on research and development 2006-2023
- Merck & Co cash dividends declared 2006-2023
- Pfizer's ad spending 2006-2023
- Pfizer's revenues in the U.S. and abroad 2009-2023
- Sales of Johnson & Johnson worldwide 2011-2023, by segment
- Sales of Johnson & Johnson 2006-2023 by region
- Johnson & Johnson's number of employees 2004-2023
- GSK's operating profit by division 2006-2021
Further Content: You might find this interesting as well
Statistics
- Merck & Co total assets 2009-2023
- Sanofi's total assets 2007-2023
- Merck & Co - expenditure on research and development 2006-2023
- Merck & Co cash dividends declared 2006-2023
- Pfizer's ad spending 2006-2023
- Pfizer's revenues in the U.S. and abroad 2009-2023
- Sales of Johnson & Johnson worldwide 2011-2023, by segment
- Sales of Johnson & Johnson 2006-2023 by region
- Johnson & Johnson's number of employees 2004-2023
- GSK's operating profit by division 2006-2021
Samsung Securities. (August 25, 2017). Distribution of incrementally modified drugs approved in South Korea from 2009 to 2016, by type [Graph]. In Statista. Retrieved May 04, 2024, from https://www.statista.com/statistics/770870/south-korea-approvals-of-incrementally-modified-drugs-by-type/
Samsung Securities. "Distribution of incrementally modified drugs approved in South Korea from 2009 to 2016, by type." Chart. August 25, 2017. Statista. Accessed May 04, 2024. https://www.statista.com/statistics/770870/south-korea-approvals-of-incrementally-modified-drugs-by-type/
Samsung Securities. (2017). Distribution of incrementally modified drugs approved in South Korea from 2009 to 2016, by type. Statista. Statista Inc.. Accessed: May 04, 2024. https://www.statista.com/statistics/770870/south-korea-approvals-of-incrementally-modified-drugs-by-type/
Samsung Securities. "Distribution of Incrementally Modified Drugs Approved in South Korea from 2009 to 2016, by Type." Statista, Statista Inc., 25 Aug 2017, https://www.statista.com/statistics/770870/south-korea-approvals-of-incrementally-modified-drugs-by-type/
Samsung Securities, Distribution of incrementally modified drugs approved in South Korea from 2009 to 2016, by type Statista, https://www.statista.com/statistics/770870/south-korea-approvals-of-incrementally-modified-drugs-by-type/ (last visited May 04, 2024)
Distribution of incrementally modified drugs approved in South Korea from 2009 to 2016, by type [Graph], Samsung Securities, August 25, 2017. [Online]. Available: https://www.statista.com/statistics/770870/south-korea-approvals-of-incrementally-modified-drugs-by-type/